Journal
RHEUMATOLOGY
Volume 50, Issue 1, Pages 16-24Publisher
OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keq155
Keywords
NDB; Registry; Data Bank; National Data Bank for rheumatic diseases
Categories
Funding
- Bristol Myers Squibb
- UCB
- Pfizer
Ask authors/readers for more resources
The National Data Bank (NDB) for rheumatic diseases is a patient-based multi-disease, multi-purpose rheumatic disease registry that has been used primarily to study patients with RA, SLE, FM and OA. It enrols patients from the community, follows up with questionnaires and validates key patient data using medical records. Rheumatologist-written programs make NDB data immediately available to analysts. The NDB has been used to develop and validate diagnostic criteria, develop new questionnaires, describe illness and comorbid disease, assesses disease outcomes and the effect of therapeutic interventions, and measure costs and cost-effectiveness.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available